Clinical Trial: Fetal Hemoglobin Induction Treatment Metformin

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Use of Metformin as a Fetal Hemoglobin Inducer in Patients With Hemoglobinopathies

Brief Summary: The purpose of this study is to determine whether metformin is effective in the treatment for sickle cell anemia (SCA) and non-transfusion dependent thalassemia (NTDT).